Why NxStage put trade may be bullish

By
A A A

One investor is using options to manage a trade in NxStage Medical.

Our tracking systems detected the sale of 3,300 December 15 puts for about $1.52 against no previous open interest. He or she is now obligated to buy shares for $15 if they drop to that level.

The benefit of the strategy is that if the stock never goes that low, the trader simply keeps the premium and the puts will expire worthless. Below $15, the trader will be assigned stock, but the effective entry price would be $13.48. That was major consolidation range in 2007 and mid-2010, so the shares might draw buyers there again.

Selling the puts established that entry price now eliminated the need to time the purchase. (See our Education section for more on how options can be used to manage such trades .)

NXTM fell 2.54 percent to $15.34 on Friday. It rallied about 400 percent between mid-2009 and early 2011 but has been drifting lower since. The company's devices are used for treating patients with conditions such as kidney failure.

The put sale pushed total option volume in the stock to more than 100 times average levels.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Copyright © 2010 OptionMonster® Holdings, Inc. All Rights Reserved.


This article appears in: Investing , Options

Referenced Stocks: NXTM

optionMONSTER

optionMONSTER

More from optionMONSTER:

Related Videos

Stocks

Referenced

Most Active by Volume

107,117,829
  • $6.82 ▲ 14.81%
102,077,403
  • $11.80 ▲ 12.06%
90,081,216
  • $3.405 ▲ 0.74%
75,589,719
  • $36.61 ▲ 2.69%
47,507,076
  • $39.98 ▲ 6.02%
42,234,051
  • $15.37 ▼ 0.84%
41,644,835
  • $6.56 ▼ 1.94%
38,874,276
  • $98.505 ▼ 0.52%
As of 7/29/2014, 03:51 PM